YOLT-204 in Patients With Hemoglobinopathies

Clinical trial NCT07190001 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07190001
Sponsor: Guangzhou Women and Children's Medical Center
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Hemoglobinopathies (Transfusion-dependent β-thalassemia and Sickle Cell Disease)

Start date: 2025-09-30
Primary completion: 2027-04-30
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.